Indian tech giant Infosys revealed some big plans yesterday.
The company announced that it had signed a definitive agreement to acquire Denmark-based BASE Life Sciences – leading technology and consulting firm in the life sciences industry, for about $111 million.
The all-cash deal will deepen its footprints in the life sciences domain as well as strengthen its presence in the Nordics region and across Europe.
The deal is expected to close by Q2 of FY23
The life sciences vertical currently contributes 6.6% to Infosys’ total revenues. It grew 16.2% year-on-year in constant currency for the March quarter.
With nearly 200 multidisciplinary industry experts across Denmark, Switzerland, the UK, Germany, France, Italy, and a nearshore technology hub in Spain, BASE is among the fastest-growing in technology and consulting in the life sciences industry.
Together with Infosys, BASE will further expand its portfolio of expertise into Consumer Health, Animal Health, MedTech, and Genomics segments.
BASE also offers business consulting and technology services, helping global life sciences companies realise business value from cloud-first digital platforms and data to speed-up clinical trials and scale drug development.
The Denmark-headquartered firm will bring home its expertise in Data & AI, business logic, and technology to drive insights for better health outcomes.
Too long? Here’s a one-liner: Infosys to acquire Denmark-based BASE Life Sciences for $111 million in an all-cash deal to be closed by 2023